Patent №
US 8,735,599
Granted
2014-05-27
Filed 2012
Owner
CHIRON CORPORATION
+1 more
Lab
—
AI components
1
vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
13613977
The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
AI classification
Ownership
CHIRON CORPORATION
assignment · 294700786
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
merger · 294710390
Assignors
JAZAN, ELISA, WANG, WEIBO, BARSANTI, PAUL A., XIA, YI, PECCHI, SABINA, BRAMMEIER, NATHAN, PHILLIPS, MEGAN, MENDENHALL, KRIS, WAYMAN, KELLY, LAGNITON, LIANA MARIE, YANG, HONG, MIEULI, ELIZABETH, +8 more
On an employer assignment, the assignors are typically the inventors.